Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis
Qian Yu, Yunlei Tong, Lian Cui, et al.
International Immunopharmacology (2019) Vol. 73, pp. 442-450
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2021) Vol. 2021, Iss. 12
Open Access | Times Cited: 135
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 109
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 92
Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease
Sandeep Arora, Pankaj Das, Gulhima Arora
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis
Serafinella Patrizia Cannavò, Lucrezia Bertino, Eleonora Di Salvo, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 31
Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
Ting-Ting Cheng, Yang Lo
Dermatologica Sinica (2025)
Open Access
Apoptosis in Autoimmunological Diseases, with Particular Consideration of Molecular Aspects of Psoriasis
Agata Krawczyk, Joanna Miśkiewicz, Karolina Strzelec, et al.
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 25
A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries
Jui Vyas, Jeffrey Johns, F.M. Ali, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 3, pp. 315-339
Open Access | Times Cited: 8
Immune cell activity during anti-TNF treatment in patients with psoriasis and psoriatic arthritis
Aleksandra Petrović, Victoria Marie Samuelsen, Richard Davies, et al.
Clinical & Experimental Immunology (2024) Vol. 218, Iss. 3, pp. 329-340
Open Access | Times Cited: 3
Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: A meta‐analysis of randomized controlled trials
Yan Xie, Yang Liu, Yi Liu
Dermatologic Therapy (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 20
Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model
Le Kuai, Ying Luo, Keshen Qu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 6, pp. 1219-1241
Open Access | Times Cited: 6
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial
Lunfei Liu, Ji-Su Chen, Jun Gu, et al.
Archives of Dermatological Research (2019) Vol. 312, Iss. 6, pp. 437-445
Closed Access | Times Cited: 17
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
Juan José Lluch‐Galcerá, J.M. Carrascosa, Alicia González-Quesada, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 3, pp. 355-363
Closed Access | Times Cited: 5
The HLA-Cw*06 allele may predict the response to methotrexate (MTX) treatment in Chinese arthritis-free psoriasis patients
Manyun Mao, Yehong Kuang, Menglin Chen, et al.
Archives of Dermatological Research (2022)
Closed Access | Times Cited: 7
Prevalence of positive tuberculin skin test in a Brazilian sample of rheumatoid arthritis and spondylarthritis patients
Beatriz Silva Lemes, Carina Albuquerque Roberto, André Rochinski Busanello, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 2
Open Access | Times Cited: 1
Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis
Daniel G. Fernández‐Ávila, Wilson Bautista‐Molano, María Lorena Brance, et al.
The Journal of Rheumatology (2024), pp. jrheum.2023-1172
Open Access | Times Cited: 1
The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients
M. Chen, Wei Chen, Pan Liu, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 9, pp. 2059-2065
Closed Access | Times Cited: 10
Long‐term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)‐α antagonists versus TNF‐α antagonists alone in psoriatic patients
Jochen Hoffmann, Christian Knoop, K. Schäkel, et al.
The Journal of Dermatology (2021) Vol. 48, Iss. 6, pp. 835-843
Open Access | Times Cited: 6
Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists
E. Mahé, Alain Beauchet, S. Hadj‐Rabia, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Open Access | Times Cited: 4
TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients
Vanessa Lucília Silveira de Medeiros, Fabiana Cristina Fulco Santos, Lílian Maria Lapa Montenegro, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0242098-e0242098
Open Access | Times Cited: 3
Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic Nanobiocomposites
Pankaj Singh Patel, Rajnish Srivastava, Sunita Panchawat
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 2, pp. 220-236
Closed Access | Times Cited: 1
A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents
Sam Polesie, Farzad Alinaghi, Alexander Egeberg
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Serum interleukin-33 level may serve as a new marker for psoriasis diagnosis
Marwa A. Abdel-Wahed, Mohammed H. Elmogy, M. Abdel‐Salam, et al.
Egyptian Journal of Dermatology and Venerology (2021) Vol. 41, Iss. 2, pp. 109-114
Closed Access | Times Cited: 1
Combination Therapy with Biologic Agents
Kourtney Pony, Mio Nakamura
Updates in clinical dermatology (2022), pp. 53-63
Closed Access
Page 1 - Next Page

Scroll to top